| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,641 |
5,942 |
$475K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,910 |
6,992 |
$419K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
264 |
263 |
$27K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
173 |
172 |
$16K |
| 90682 |
|
288 |
286 |
$16K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,544 |
1,517 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
90 |
88 |
$9K |
| 99051 |
|
1,081 |
1,037 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
395 |
391 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
510 |
450 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
1,610 |
1,547 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
260 |
158 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
266 |
261 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
484 |
479 |
$3K |
| 90688 |
|
315 |
314 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
25 |
25 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
54 |
51 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
64 |
58 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
15 |
15 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
32 |
31 |
$906.75 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12 |
12 |
$884.88 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
134 |
108 |
$376.68 |
| 81003 |
|
254 |
238 |
$350.65 |
| 90686 |
|
104 |
104 |
$345.44 |
| 81002 |
|
45 |
41 |
$114.65 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
12 |
$99.68 |
| 96127 |
|
27 |
27 |
$95.47 |
| 98966 |
|
72 |
64 |
$0.72 |
| G9920 |
Screening performed and negative |
37 |
35 |
$0.00 |
| 3075F |
|
177 |
166 |
$0.00 |
| 3074F |
|
1,738 |
1,496 |
$0.00 |
| 3079F |
|
1,978 |
1,682 |
$0.00 |